Chang Xia

2.3k total citations · 1 hit paper
15 papers, 1.9k citations indexed

About

Chang Xia is a scholar working on Cancer Research, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Chang Xia has authored 15 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 2 papers in Geriatrics and Gerontology. Recurrent topics in Chang Xia's work include Cancer, Hypoxia, and Metabolism (5 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Epigenetics and DNA Methylation (2 papers). Chang Xia is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Epigenetics and DNA Methylation (2 papers). Chang Xia collaborates with scholars based in United States and China. Chang Xia's co-authors include Bing‐Hua Jiang, Jing Fang, Meng Qiao, Yon Rojanasakul, Xianglin Shi, Liu L, Zongxian Cao, G. Keith Harris, H. Klandorf and Stephen S. Leonard and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Chang Xia

14 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

2003 577 citations Stephen S. Leonard, Chang Xia et al. Biochemical and Biophysical Research Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chang Xia United States	10	1.1k	441	334	265	219	15	1.9k
Anjana Bhardwaj United States	17	1.4k 1.3×	440 1.0×	700 2.1×	377 1.4×	170 0.8×	37	2.6k
Monica Savio Italy	25	1.2k 1.2×	236 0.5×	413 1.2×	569 2.1×	210 1.0×	44	2.1k
Jeong‐Hyeon Ko South Korea	22	1.1k 1.1×	352 0.8×	271 0.8×	475 1.8×	90 0.4×	38	2.1k
Jean‐François Savouret France	27	779 0.7×	208 0.5×	435 1.3×	153 0.6×	273 1.2×	41	2.1k
Moammir Hasan Aziz United States	23	1.2k 1.1×	262 0.6×	405 1.2×	450 1.7×	83 0.4×	33	2.1k
Julián Carretero Spain	32	1.8k 1.7×	580 1.3×	250 0.7×	638 2.4×	153 0.7×	59	2.9k
Bruna Pucci Italy	19	986 0.9×	289 0.7×	264 0.8×	461 1.7×	153 0.7×	26	1.9k
Anait S. Levenson United States	32	1.9k 1.8×	661 1.5×	522 1.6×	638 2.4×	83 0.4×	63	3.1k
Michael Y. Bonner United States	20	720 0.7×	211 0.5×	182 0.5×	229 0.9×	185 0.8×	36	1.5k
Shuai Huang China	24	1.2k 1.1×	764 1.7×	152 0.5×	340 1.3×	178 0.8×	69	2.1k

Countries citing papers authored by Chang Xia

Since Specialization

Citations

This map shows the geographic impact of Chang Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Xia more than expected).

Fields of papers citing papers by Chang Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Xia. The network helps show where Chang Xia may publish in the future.

Co-authorship network of co-authors of Chang Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Xia. A scholar is included among the top collaborators of Chang Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Xia. Chang Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Thomas, Alexandra, et al.. (2015). Frequency and Clinical Significance of Extramammary Findings on Breast Magnetic Resonance Imaging. Clinical Breast Cancer. 16(5). 424–429. 6 indexed citations

Xia, Chang, et al.. (2014). Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide). Cancer Chemotherapy and Pharmacology. 74(4). 691–697. 55 indexed citations

Xia, Chang, Mary C. Schroeder, Ronald J. Weigel, Sonia L. Sugg, & Alexandra Thomas. (2014). Rate of Contralateral Prophylactic Mastectomy is Influenced by Preoperative MRI Recommendations. Annals of Surgical Oncology. 21(13). 4133–4138. 13 indexed citations

Xia, Chang, Mary C. Schroeder, Ronald J. Weigel, Sonia L. Sugg, & Alexandra Thomas. (2014). Effect of contralateral prophylactic mastectomy on quality of life in women undergoing surgery for breast cancer: A prospective study.. Journal of Clinical Oncology. 32(15_suppl). 9566–9566.

Faisal, Farzana A., Hua-Ling Tsai, Amanda L. Blackford, et al.. (2013). Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 39(1). 18–26. 16 indexed citations

Xia, Chang, et al.. (2012). A phase I/II study to evaluate the ability of decitabine and panobinostat to improve temozolomide chemosensitivity in metastatic melanoma.. Journal of Clinical Oncology. 30(15_suppl). 3056–3056. 2 indexed citations

Bai, Li, Zhiming Hu, Fei Wang, et al.. (2012). Generation of streptavidin-tagged human-granulocyte macrophage colony-stimulating factor fusion proteins.. PubMed. 32(10). 1389–93. 1 indexed citations

Xia, Chang, Meng Qiao, Liu L, et al.. (2007). Reactive Oxygen Species Regulate Angiogenesis and Tumor Growth through Vascular Endothelial Growth Factor. Cancer Research. 67(22). 10823–10830. 407 indexed citations

L, Liu, Zhongyi Hu, Chang Xia, et al.. (2006). Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radical Biology and Medicine. 41(10). 1521–1533. 169 indexed citations

10.

Xia, Chang, Meng Qiao, Zongxian Cao, Xianglin Shi, & Bing‐Hua Jiang. (2006). Regulation of angiogenesis and tumor growth by p110 Alpha and AKT1 via VEGF expression. Journal of Cellular Physiology. 209(1). 56–66. 61 indexed citations

11.

Qiao, Meng, Chang Xia, Jing Fang, Yon Rojanasakul, & Bing‐Hua Jiang. (2006). Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cellular Signalling. 18(12). 2262–2271. 184 indexed citations

12.

Fang, Jing, Chang Xia, Zongxian Cao, et al.. (2005). Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. The FASEB Journal. 19(3). 342–353. 270 indexed citations

13.

Cao, Zongxian, Jing Fang, Chang Xia, Xianglin Shi, & Bing‐Hua Jiang. (2004). trans- 3,4,5′-Trihydroxystibene Inhibits Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor Expression in Human Ovarian Cancer Cells. Clinical Cancer Research. 10(15). 5253–5263. 140 indexed citations

14.

Leonard, Stephen S., et al.. (2003). Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochemical and Biophysical Research Communications. 309(4). 1017–1026. 577 indexed citations breakdown →

15.

Xia, Chang. (2003). Evaluation of Clinical Usage of Bicyclol in the Treatment of Chronic HCV. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact